Scarica l'app Stockscreener
24.60
93.55%
11.89
Dopo l'orario di chiusura:
20.86
-3.74
-15.20%
Precedente Chiudi:
$12.71
Aprire:
$21.29
Volume 24 ore:
4.31M
Relative Volume:
48.65
Capitalizzazione di mercato:
$173.92M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+371.26%
1M Prestazione:
+241.67%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$15.30
$24.88
Intervallo di 1 settimana:
$4.55
$24.88
Portata 52W:
$4.40
$24.88
Liminatus Pharma Inc Stock (LIMN) Company Profile
Nome
Liminatus Pharma Inc
Settore
Industria
Telefono
213-273-5453
Indirizzo
6 CENTERPOINTE DR., LA PALMA
Confronta LIMN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
24.60 | 657.18M | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
6.70 | 1.93B | 2.82B | -191.60M | -407.10M | -0.6794 |
|
AACT
Ares Acquisition Corporation Ii
|
11.42 | 699.01M | 0 | 16.92M | -1.35M | 0.29 |
|
CEP
Cantor Equity Partners Inc
|
40.22 | 514.82M | 0 | 0 | 0 | 0.00 |
|
EQV
Eqv Ventures Acquisition Corp
|
10.51 | 464.45M | 0 | 0 | 0 | 0.00 |
|
ANSC
Agriculture Natural Solutions Acquisition Corp
|
10.77 | 463.59M | 0 | 1.30M | 0 | 0.0301 |
Liminatus Pharma Inc Borsa (LIMN) Ultime notizie
Greif Posts Upbeat Earnings, Joins Planet Labs PBC, IperionX, Owens & Minor And Other Big Stocks Moving Higher On Thursday - Benzinga
Crude Oil Moves Higher; Ciena Posts Downbeat Earnings - Benzinga
Liminatus Pharma stock gains on regaining compliance with Nasdaq - Seeking Alpha
Dow Dips Over 100 Points; US Jobless Claims Increase - Benzinga
Liminatus Pharma shares soar on Nasdaq compliance news By Investing.com - Investing.com Canada
Liminatus Pharma shares soar on Nasdaq compliance news - Investing.com India
Pre-market Movers: LIMN, KRON, HSDT, CBUS... - RTTNews
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Liminatus Pharma Gains Compliance With Nasdaq Filing Requirements; Shares up Pre-Bell - marketscreener.com
Liminatus Pharma Stock Surges to Record High After Regaining Nasdaq Compliance - Asianet Newsable
Liminatus Pharma regains Nasdaq listing compliance - TipRanks
Liminatus Pharma Regains Nasdaq Compliance After Filing Delay - TipRanks
Liminatus Pharma, Inc.Class A Common Stock (Nasdaq:LIMN) Stock Quote - FinancialContent
Liminatus Pharma Delays Quarterly Report Filing - TipRanks
Liminatus Pharma’s Merger with Iris Acquisition Corp. - Global Legal Chronicle
Iris Acquisition, Liminatus Pharma Sign SPAC Merger Deal - marketscreener.com
LIMN Stock Price and Chart — NASDAQ:LIMN - TradingView
Iris Acquisition Corp confirms delisting and shareholder vote outcomes - Investing.com
Iris Acquisition Corp announces preliminary proxy statement - Investing.com
Iris Acquisition Corp announces business combination - Investing.com
Iris Acquisition Corp announces business combination with Liminatus Pharma - Investing.com
New company Liminatus Pharma Inc to develop three cancer treatments - Labiotech.eu
A fledgling biotech goes SPAC route to bankroll cancer vaccine, CAR-T and CD47 - Endpoints News
Liminatus Pharma and Iris Acquisition to Combine in $334M Deal - The SPAC Conference
Liminatus Pharma and Iris Acquisition Corp to Combine - citybiz
Holland & Knight Partner Seth Belzley Ranked Among Denver’s Outstanding "40 Under 40" Business Professionals - Holland & Knight
Liminatus Pharma Inc Azioni (LIMN) Dati Finanziari
Non sono disponibili dati finanziari per Liminatus Pharma Inc (LIMN). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.00%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):